FDA OKs Guselkumab for Crohn’s Disease ...Middle East

Medscape - News
FDA OKs Guselkumab for Crohn’s Disease
Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for moderately to severely active Crohn’s disease. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Guselkumab for Crohn’s Disease )

Also on site :



Latest News